Porcilis PCV M Hyo is used to protect pigs against two of the most important diseases in pigs porcine circovirus associated diseases and Enzootic pneumonia, caused by Mycoplasma hyopneumoniae. • Porcine circovirus type 2 (PCV2) infections can produce clinical signs such as wasting, weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, diarrhoea, pale skin and jaundice (yellowing of the skin). • Infection with the bacterium Mycoplasma hyopneumoniae in pigs is responsible for the development of enzootic pneumonia. Affected pigs have a dry cough and fail to thrive, with important consequences to their growth performance. Target species - Pigs for fattening Indications for use For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (PCV2) infection, and severity of lung lesions caused by Mycoplasma hyopneumoniae infection. To reduce the loss of daily weight gain during the finishing period in face of infections with Mycoplasma hyopneumoniae and/or PCV2 (as observed in field studies). Onset of immunity with single dose vaccination: PCV2: 2 weeks after vaccination M. hyopneumoniae: 4 weeks after vaccination. Onset of immunity with two dose vaccination: PCV2: 18 days after first vaccination M. hyopneumoniae: 3 weeks after the second vaccination. Duration of immunity (both vaccination schedules): PCV2: 22 weeks after (the last) vaccination M. hyopneumoniae: 21 weeks after (the last) vaccination Withdrawal periods - Pigs – meat 0 days
